Top

Published in:

01-02-2014 | Clinical Study

CUL4A is overexpressed in human pituitary adenomas and regulates pituitary tumor cell proliferation

Authors: Yangyang Xu, Yunshan Wang, Guangxin Ma, Qin Wang, Guangwei Wei

Published in: Journal of Neuro-Oncology | Issue 3/2014

Abstract

Cullin 4A (CUL4A) encodes a core subunit of an E3 ubiquitin ligase that targets proteins for ubiquitin-mediated degradation, and aberrant expression of the CUL4A is found in many tumor types. However, its roles and clinicopathologic significance in pituitary adenomas are not clear. The aim of this study was to investigate the possible role of CUL4A in pituitary tumorigenesis. Immunohistochemistry was used to examine CUL4A expression in human normal pituitaries and pituitary tumors with respect to various clinicopathologic factors in pituitary adenomas. Cell proliferation was assessed by MTT and colony formation, and migration and invasion were analyzed by Transwell and Matrigel assays after CUL4A overexpression or knockdown in pituitary tumor cells. Overexpression of CUL4A was frequently observed in pituitary adenomas compared with normal adenohypophysial tissue and significantly associated with tumor progressiveness and invasion. CUL4A overexpression in GH3 adenoma cells increased colony numbers, cell viability and cell invasion and silencing CUL4A in AtT20 adenoma cells decreased cell proliferation, migration and invasion. Mechanistically, CUL4A could modulate the expression of p53, p21, and p27 in pituitary tumor cells. In addition, high levels of CUL4A expression also significantly inversely correlated with the p53 protein level in human pituitary adenomas. Our results indicate that CUL4A enhances pituitary cell proliferation, migration and invasion and may thus contribute to pituitary tumor development and progression.

Available only for authorised users

Shiyanov P, Nag A, Raychaudhuri P (1999) Cullin 4A associates with the UV-damaged DNA-binding protein DDB. J Biol Chem 274:35309–35312PubMedCrossRef

He YJ, McCall CM, Hu J, Zeng Y, Xiong Y (2006) DDB1 functions as a linker to recruit receptor WD40 proteins to CUL4-ROC1 ubiquitin ligases. Genes Dev 20:2949–2954PubMedCrossRef

Chen LC, Manjeshwar S, Lu Y, Moore D, Ljung BM, Kuo WL, Dairkee SH, Wernick M, Collins C, Smith HS (1998) The human homologue for the Caenorhabditis elegans cul-4 gene is amplified and overexpressed in primary breast cancers. Cancer Res 58:3677–3683PubMed

Shinomiya T, Mori T, Ariyama Y, Sakabe T, Fukuda Y, Murakami Y, Nakamura Y, Inazawa J (1999) Comparative genomic hybridization of squamous cell carcinoma of the esophagus: the possible involvement of the DPI gene in the 13q34 amplicon. Genes Chromosomes Cancer 24:337–344PubMedCrossRef

Dohna M, Reincke M, Mincheva A, Allolio B, Solinas-Toldo S, Lichter P (2000) Adrenocortical carcinoma is characterized by a high frequency of chromosomal gains and high-level amplifications. Genes Chromosomes Cancer 28:145–152PubMedCrossRef

Michiels EM, Weiss MM, Hoovers JM, Baak JP, Voute PA, Baas F, Hermsen MA (2002) Genetic alterations in childhood medulloblastoma analyzed by comparative genomic hybridization. J Pediatr Hematol Oncol 24:205–210PubMedCrossRef

Yasui K, Arii S, Zhao C, Imoto I, Ueda M, Nagai H, Emi M, Inazawa J (2002) TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas. Hepatology 35:1476–1484PubMedCrossRef

Hung MS, Mao JH, Xu Z, Yang CT, Yu JS, Harvard C, Lin YC, Bravo DT, Jablons DM, You L (2011) Cul4A is an oncogene in malignant pleural mesothelioma. J Cell Mol Med 15:350–358PubMedCentralPubMedCrossRef

Birner P, Schoppmann A, Schindl M, Dinhof C, Jesch B, Berghoff AS, Schoppmann SF (2012) Human homologue for Caenorhabditis elegans CUL-4 protein overexpression is associated with malignant potential of epithelial ovarian tumours and poor outcome in carcinoma. J Clin Pathol 65:507–511PubMedCrossRef

10.

Marko NF, Weil RJ (2012) Pituitary gland: new pathways in the pathogenesis of pituitary adenomas. Nat Rev Endocrinol 8:572–573PubMedCrossRef

11.

Sharif-Alhoseini M, Rahimi-Movaghar V (2012) Pituitary adenomas: a review. J Inj Violence Res 4(3 Suppl 1):56

12.

Righi A, Agati P, Sisto A, Frank G, Faustini-Fustini M, Agati R, Mazzatenta D, Farnedi A, Menetti F, Marucci G, Foschini MP (2012) A classification tree approach for pituitary adenomas. Hum Pathol 43:1627–1637PubMedCrossRef

13.

Pratheesh R, Rajaratnam S, Prabhu K, Mani SE, Chacko G, Chacko AG (2012) The current role of transcranial surgery in the management of pituitary adenomas. Pituitary 16:419–434CrossRef

14.

Zhou Y, Zhang X, Klibanski A (2013) Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma. Mol Cell Endocrinol. doi:10.1016/j.mce.2013.09.006

15.

Suhardja AS, Kovacs KT, Rutka JT (1999) Molecular pathogenesis of pituitary adenomas: a review. Acta Neurochir (Wien) 141:729–736CrossRef

16.

Nag A, Bagchi S, Raychaudhuri P (2004) Cul4A physically associates with MDM2 and participates in the proteolysis of p53. Cancer Res 64:8152–8155PubMedCrossRef

17.

Lu X, Guo J, Hsieh TC (2003) PC-SPES inhibits cell proliferation by modulating p21, cyclins D, E and B and multiple cell cycle-related genes in prostate cancer cells. Cell Cycle 2:59–63PubMedCrossRef

18.

Higa LA, Banks D, Wu M, Kobayashi R, Sun H, Zhang H (2006) L2DTL/CDT2 interacts with the CUL4/DDB1 complex and PCNA and regulates CDT1 proteolysis in response to DNA damage. Cell Cycle 5:1675–1680PubMedCrossRef

19.

Li B, Jia N, Kapur R, Chun KT (2006) Cul4A targets p27 for degradation and regulates proliferation, cell cycle exit, and differentiation during erythropoiesis. Blood 107:4291–4299PubMedCrossRef

20.

Jiang L, Rong R, Sheikh MS, Huang Y (2011) Cullin-4A.DNA damage-binding protein 1 E3 ligase complex targets tumor suppressor RASSF1A for degradation during mitosis. J Biol Chem 286:6971–6978PubMedCrossRef

21.

Gejman R, Swearingen B, Hedley-Whyte ET (2008) Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas. Hum Pathol 39:758–766PubMedCrossRef

22.

Botelho CH, Magalhaes AV, Mello PA, Schmitt FC, Casulari LA (2006) Expression of p53, Ki-67 and c-erb B2 in growth hormone-and/or prolactin-secreting pituitary adenomas. Arq Neuropsiquiatr 64:60–66PubMedCrossRef

23.

Banks D, Wu M, Higa LA, Gavrilova N, Quan J, Ye T, Kobayashi R, Sun H, Zhang H (2006) L2DTL/CDT2 and PCNA interact with p53 and regulate p53 polyubiquitination and protein stability through MDM2 and CUL4A/DDB1 complexes. Cell Cycle 5:1719–1729PubMedCrossRef

24.

McCutcheon IE (2013) Pituitary adenomas: surgery and radiotherapy in the age of molecular diagnostics and pathology. Curr Probl Cancer 37:6–37PubMedCrossRef

25.

Huh J, Piwnica-Worms H (2013) CRL4(CDT2) targets CHK1 for PCNA-independent destruction. Mol Cell Biol 33:213–226PubMedCentralPubMedCrossRef

26.

Lee J, Zhou P (2012) Pathogenic role of the CRL4 ubiquitin ligase in human disease. Front Oncol 2:21PubMedCentralPubMed

27.

Schindl M, Gnant M, Schoppmann SF, Horvat R, Birner P (2007) Overexpression of the human homologue for Caenorhabditis elegans cul-4 gene is associated with poor outcome in node-negative breast cancer. Anticancer Res 27:949–952PubMed

28.

Waning DL, Li B, Jia N, Naaldijk Y, Goebel WS, HogenEsch H, Chun KT (2008) Cul4A is required for hematopoietic cell viability and its deficiency leads to apoptosis. Blood 112:320–329PubMedCrossRef

29.

Bondar T, Kalinina A, Khair L, Kopanja D, Nag A, Bagchi S, Raychaudhuri P (2006) Cul4A and DDB1 associate with Skp2 to target p27Kip1 for proteolysis involving the COP9 signalosome. Mol Cell Biol 26:2531–2539PubMedCentralPubMedCrossRef

30.

Higa LA, Yang X, Zheng J, Banks D, Wu M, Ghosh P, Sun H, Zhang H (2006) Involvement of CUL4 ubiquitin E3 ligases in regulating CDK inhibitors Dacapo/p27Kip1 and cyclin E degradation. Cell Cycle 5:71–77PubMedCrossRef

31.

Zemmoura I, Wierinckx A, Vasiljevic A, Jan M, Trouillas J, Francois P (2012) Aggressive and malignant prolactin pituitary tumors: pathological diagnosis and patient management. Pituitary 16:515–522CrossRef

Title: CUL4A is overexpressed in human pituitary adenomas and regulates pituitary tumor cell proliferation
Authors: Yangyang Xu
Yunshan Wang
Guangxin Ma
Qin Wang
Guangwei Wei
Publication date: 01-02-2014
Publisher: Springer US
Published in: Journal of Neuro-Oncology / Issue 3/2014
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-013-1349-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

CUL4A is overexpressed in human pituitary adenomas and regulates pituitary tumor cell proliferation

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2014

Short-interval estimation of proliferation rate using serial diffusion MRI predicts progression-free survival in newly diagnosed glioblastoma treated with radiochemotherapy

A systematic review of inhaled intranasal therapy for central nervous system neoplasms: an emerging therapeutic option

Mouse glioma immunotherapy mediated by A2B5+ GL261 cell lysate-pulsed dendritic cells

A rare infectious presentation of a temporal bone meningioma

Effect of contrast leakage on the detection of abnormal brain tumor vasculature in high-grade glioma

Effects of the estrogen receptor antagonist fulvestrant on F344 rat prolactinoma models